Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine.
The new antiviral agent, azidothymidine (AZT; BW A509U), is currently the only successful drug in use for patients with acquired immunodeficiency syndrome. The effect of this thymidine analog, 3'-azido-3'-deoxythymidine, on the replication of the lymphadenopathy-associated virus strain of the human...
Guardat en:
| Publicat a: | J Virol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1987
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC255991/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2446006/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.61.12.3769-3773.1987 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|